Induction Treatment of Acute Myeloid Leukemia in an Elderly Patient With Intra-marrow Injection of Cytarabine (Ara-C)

被引：0
|
作者：
Islam, Anwarul [1 ]
机构：
[1] Buffalo Gen Med Ctr, Buffalo, NY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
AML; elderly; treatment; intra-marrow injection; case;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-097
引用
收藏
页码：S293 / S293
页数：1
相关论文
共 50 条
  • [31] PHASE I-II STUDY OF IDARUBICIN AND CYTARABINE (ARA-C) IN ACUTE-LEUKEMIA
    BERMAN, E
    ARLIN, Z
    DAGHESTANI, A
    GEE, T
    KEMPIN, S
    MERTELSMANN, R
    ANDREEF, M
    HANCOCK, C
    BARATZ, R
    WILLIAMS, L
    CLARKSON, B
    YOUNG, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 187 - 187
  • [32] TREATMENT OF REFRACTORY AND RECIDIVIST ACUTE MYELOID-LEUKEMIA WITH HIGH-DOSE ARA-C AND AMSACRINE
    KALHS, P
    KOS, M
    JAGER, U
    SCHWARZINGER, I
    BETTELHEIM, P
    PANZER, S
    HINTERBERGER, W
    NEUMANN, E
    LECHNER, K
    ONKOLOGIE, 1987, 10 (05): : 279 - 280
  • [33] Ara-C, Idarubicine and Gentuzumab Ozogamicin (AIM) as Salvage Treatment in Advanced Acute Myeloid Leukemia Patients
    Capria, Saveria
    Trisolini, Silvia Maria
    Minotti, Clara
    Stefanizzi, Caterina
    Cardarelli, Luisa
    Canichella, Martina
    Cartoni, Claudio
    Diverio, Daniela
    De Propris, Maria Stefania
    Mancini, Marco
    Micozzi, Alessandra
    Foa, Robin
    Meloni, Giovanna
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2012, 4 (01):
  • [34] Treatment of acute myelogenous leukemia in the older patient with attenuated high-dose ara-C
    Letendre, L
    Noel, P
    Litzow, MR
    Hoagland, HC
    Tefferi, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (02): : 142 - 144
  • [35] Allogeneic bone marrow transplantation compared with high-dose Ara-C postremission therapy in acute myeloid leukemia
    Link, H
    BONE MARROW TRANSPLANTATION, 1998, 22 : S16 - S16
  • [36] TREATMENT OF ACUTE MYELOBLASTIC-LEUKEMIA WITH ARA-C IN LOW DOSAGE
    PESCE, A
    CASSUTO, JP
    BAYLE, J
    FUZIBET, JG
    RAYNAUD, S
    GRATECOS, N
    DUJARDIN, P
    PRESSE MEDICALE, 1985, 14 (43): : 2198 - 2198
  • [37] Allogeneic bone marrow transplantation compared with high-dose ARA-C postremission therapy in acute myeloid leukemia
    Link, H
    Ehninger, G
    SchonrockNabulsi, P
    Gramatzki, M
    Daoud, A
    Tischler, J
    Brack, N
    Otremba, B
    Lutz, M
    Gackle, R
    Ohl, S
    Heidemann, E
    Gieseler, F
    Loffler, B
    Weiss, J
    Geer, T
    Wandt, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 840 - 840
  • [38] A Single Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) for Treatment of Patients with Relapsed or Refractory Acute Myeloid Leukemia
    Christian, Sonia
    Patel, Pritesh
    Esen, Aysenur
    Khan, Irum
    Sweiss, Karen
    Ghanem, Fares
    Sequeira, Christopher A.
    Shergill, Ardaman
    Quigley, John G.
    BLOOD, 2017, 130
  • [39] Clofarabine and clofarabine plus low-dose cytarabine (ara-C) as induction therapy for patients (pts) ≥ 60 years with newly diagnosed acute myeloid leukemia (AML)
    Faderl, S
    Ravandi, F
    Ferrajoli, A
    Garcia-Manero, G
    Estrov, Z
    Thomas, DA
    O'Brien, S
    Verstovsek, S
    Wierda, W
    Cortes, J
    Giles, FJ
    Kwari, M
    Jarmon, R
    Kantarjian, HM
    BLOOD, 2005, 106 (11) : 786A - 786A
  • [40] Treatment of acute myeloid leukemia in the elderly patient
    Kuse, R
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 125 (09) : 272 - 272
12345